Celldex News, Celldex Quote, CLDX Quote

Celldex (NQ:CLDX) Delayed: 31.27 --0 (-0%)

Prev. Close

$31.27

Today 6M 1Y 5Y

Open

$31.27

52 Wk High

$18.62

52 Wk Low

$2.85

Day High

$31.27

Day Low

$31.27

P/E

N/A

EPS

$-1.02

Volume

318

Friends, Peers and Foes (?): NBI ORKA (more...)

ALERTS | RSS

Jun 14, 2026 02:00 PM Celldex reports sustained angioedema improvements 7 months post-treatment
Jun 14, 2026 10:21 AM Celldex Presents Long-Term Barzolvolimab Results Demonstrating Sustained Off-Treatment Improvement in Angioedema in Patients with CSU at the European Academy of Allergy and Clinical Immunology Annual
Jun 14, 2026 05:15 AM Celldex reports positive phase 1 results for bispecific antibody CDX-622
Jun 14, 2026 05:15 AM Celldex Presents Positive First-in-Human Results from Phase 1 Study of Novel Bispecific CDX-622 at the European Academy of Allergy and Clinical Immunology Annual Meeting
Jun 10, 2026 04:01 PM Celldex to present mast cell targeting drug data at European congress
Jun 10, 2026 04:01 PM Celldex Announces Multiple Upcoming Presentations from Leading Mast Cell Targeting Pipeline at the Upcoming 2026 European Academy of Allergy and Clinical Immunology Annual Congress
Jun 10, 2026 08:37 AM Celldex Therapeutics (CLDX) PT Raised to $45 at UBS
May 15, 2026 04:02 PM Form SCHEDULE 13G/A Celldex Therapeutics, Filed by: Kynam Capital Management, LP
May 15, 2026 02:37 PM Form SCHEDULE 13G/A Celldex Therapeutics, Filed by: Bellevue Group AG
May 13, 2026 06:04 AM Celldex Therapeutics (CLDX) PT Raised to $54 at Wells Fargo

Entities mentioned with CLDX

View All Entities